{
    "title": "US FDA approves Biogen's ALS drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12012699/US-FDA-approves-Biogens-ALS-drug.html",
    "date": "2023-04-25",
    "keywords": [
        "drug",
        "approval",
        "disease",
        "qalsody",
        "raghav",
        "mahobe",
        "bhanvi",
        "satija",
        "biogen",
        "protein",
        "gene",
        "panel",
        "food",
        "administration",
        "tuesday",
        "form",
        "sclerosis",
        "treatment",
        "cause",
        "light",
        "agencys",
        "pathway",
        "effectiveness",
        "market",
        "fda",
        "qalsodys",
        "neurofilament",
        "indicator",
        "nerve",
        "cell",
        "degeneration",
        "progression",
        "effect",
        "colin",
        "quinn",
        "neurologist",
        "medicine",
        "accumulation",
        "dismutase",
        "sod1",
        "production",
        "march",
        "favor",
        "benefit",
        "latestage",
        "study",
        "range",
        "company",
        "expense",
        "month",
        "majority",
        "insurance",
        "plan",
        "government",
        "reporting",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}